Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine

Journal of Clinical Pharmacology

Volumn 36, Issue 4, 1996, Pages 345-351

  Honig, Peter K ^a   Wortham, Dale C ^b   Lazarev, Alexander ^a   Cantilena, Louis R ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; TERFENADINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; ELECTROCARDIOGRAPHY; FEMALE; FRUIT JUICE; HEART REPOLARIZATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; QT INTERVAL;

EID: 0029879317     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04210.x     Document Type: Article

References (28)

1. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR: Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA 1993;269: 1513-1518.
2. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR: Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992,52:231-238.
3. Honig PK, Wortham DC, Zamani K, Conner DP, Cantilena LR: Effect of the macrolide antibiotics erythromycin, clarithromycin and azithromycin on the pharmacokinetics of terfenadine. Drug Invest 1994;7:148-156.
4. Garteiz DA, Hook RA, Walker BJ, Okerholm RA: Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneimittelforschung 1982;32:1185-1190.
5. Woosley RL, Chen Y, Freiman JP, Gillis RA: Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-1536.
6. Schwartz PJ, Locati E, Priori SG, Zaza A: The long QT syndrome. In, Zipes DP, Jaliffe J (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders, 1990:596-605.
7. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR: Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-2790.
8. Breimer DD, Schellens JHM, Soons PA. Nifedipine: variability in its kinetics and metabolism in man. Pharmacol Ther 1989;44: 445-454.
9. Honig PK, Smith JE, Wortham DC, Zamani K, Cantilena LR: Population variability in the pharmacokinetics of terfenadine: the case for a pseudo-polymorphism with clinical implications. Drug Metabol Drug Interact 1994;11:1-8.
10. Bailey DG, Spence JD, Munoz C, Arnold JMO: Interaction of citrus juices with felodipine. Lancet 1991;337:268-269.
11. Ducharme MP, Provenzano R, Dehoorne-Smith M, Edwards DJ: Trough concentrations of cyclosporine following administration with grapefruit juice. Br J Clin Pharmacol 1993;36:457-459.
12. Bailey DG, Arnold JMO, Munoz C, Spence JD: Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin. Clin Pharmacol Ther 1993;53:637-642.
13. Guengerich FP: Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol Lett 1994;70:133-138.
14. Coutant JE, Westmark PA, Nardella PA, Walter SM, Okerholm RA: Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Chromatogr A 1991;570:139-148.
15. Bazett HC: An analysis of the times relations of electrocardiograms. Heart 1920;7:353-370.
16. Bethea RM, Duran BS, Boullion TL: Statistical Methods For Engineers and Scientists. Second edition. New York: Marcel Dekker, 1985
17. Gibaldi M: Biopharmaceutics and Clinical Pharmacokinetics. Philadelphia: Lea and Febiger, 1984.
18. Matthews DR, McNutt B, Okerholm R, Flicker M, McBride G: Torsades de pointes occurring in association with terfenadine use (letter). JAMA 1991;266:2375-2376.
19. Benton R, Honig PK, Zamani K, Hewett J, Cantilena LR, Woosley RL: Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of QTc (abstract). Clin Pharmacol Ther 1994;55:146.
20. Gustafsson JA: Sex steroid induced changes in hepatic enzymes. Ann Rev Physiol 1983;45:51-60.
21. Gibson GG, Skett P: Introduction to Drug Metabolism. New York: Chapman and Hall, 1986.
22. Bailey DG, Arnold JMO, Spence JD: Grapefruit juice and drugs. Clin Pharmacokinet 1994;26:91-98.
23. Krishna DR, Klotz U: Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26:144-160.
24. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J: QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991;83:1888-1894.
25. Morganroth J, Brown AM, Critz S, Crumb WJ, Kunze DL, Lacerda AE, Lopez H: Variability of the QTc interval: impact of defining drug effect and low-frequency cardiac events. Am J Cardiol 1993:26B-31B.
26. Honig PK, Wortham DC, Hull R, Zamani K, Smith JE, Cantilena LR: Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol 1993;33:1201-1206.
27. Hokkinen SK, Varhe A, Olkkola KT, Neuvonen PJ: Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 1995;58:127-131.
28. Bailey DG, Malcolm OA, Spence JD: Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacokinet 1994;26:91-98.